Crossmark

Biosimilars, a new era in rheumatology in Spain

Crossref DOI link: https://doi.org/10.1016/j.reumae.2019.11.001

Published Print: 2020-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Díaz-González, Federico

Bustabad-Reyes, Sagrario
License Information

Text and Data Mining valid from 2020-03-01
More Information

This article is maintained by: Elsevier

Article Title: Biosimilars, a new era in rheumatology in Spain

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2019.11.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2019.11.009

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.